On Monday, Agenus Inc (NASDAQ: AGEN) opened higher 9.36% from the last session, before settling in for the closing price of $4.70. Price fluctuations for AGEN have ranged from $1.38 to $18.74 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -7.17% over the past five years. Company’s average yearly earnings per share was noted 74.98% at the time writing. With a float of $26.36 million, this company’s outstanding shares have now reached $26.56 million.
Let’s look at the performance matrix of the company that is accounted for 316 employees. In terms of profitability, gross margin is 24.29%, operating margin of -101.39%, and the pretax margin is -194.29%.
Agenus Inc (AGEN) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Agenus Inc is 3.85%, while institutional ownership is 32.02%.
Agenus Inc (AGEN) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.22 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 74.98% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 38.34% during the next five years compared to 7.90% growth over the previous five years of trading.
Agenus Inc (NASDAQ: AGEN) Trading Performance Indicators
Check out the current performance indicators for Agenus Inc (AGEN). In the past quarter, the stock posted a quick ratio of 0.11. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -8.68, a number that is poised to hit 1.03 in the next quarter and is forecasted to reach 1.00 in one year’s time.
Technical Analysis of Agenus Inc (AGEN)
Agenus Inc (NASDAQ: AGEN) saw its 5-day average volume 0.89 million, a positive change from its year-to-date volume of 0.74 million. As of the previous 9 days, the stock’s Stochastic %D was 33.52%. Additionally, its Average True Range was 0.50.
During the past 100 days, Agenus Inc’s (AGEN) raw stochastic average was set at 75.65%, which indicates a significant increase from 64.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 167.99% in the past 14 days, which was higher than the 118.15% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.34, while its 200-day Moving Average is $3.53. Nevertheless, the first resistance level for the watch stands at $5.32 in the near term. At $5.49, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.83. If the price goes on to break the first support level at $4.81, it is likely to go to the next support level at $4.47. Assuming the price breaks the second support level, the third support level stands at $4.30.
Agenus Inc (NASDAQ: AGEN) Key Stats
There are currently 27,417K shares outstanding in the company with a market cap of 140.92 million. Presently, the company’s annual sales total 103,460 K according to its annual income of -227,210 K. Last quarter, the company’s sales amounted to 24,070 K and its income totaled -25,270 K.
